Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2018 Oct 3;192:294–302. doi: 10.1016/j.drugalcdep.2018.07.046

Intimate relationships and patterns of drug and sexual risk behaviors among people who inject drugs in Kazakhstan: A latent class analysis*

Phillip L Marotta a,b,c, Assel Terlikbayeva a,b,c, Louisa Gilbert a,b,c, Tim Hunt a,b,c, Amar Mandavia d,e, Elwin Wu a,b,c, Nabila El-Bassel a,b,c
PMCID: PMC6415908  NIHMSID: NIHMS1509114  PMID: 30304712

Abstract

Background:

Multiple drug and sexual risk behaviors among people who inject drugs (PWID) in intimate relationships increase the risk of HIV and HCV transmission. Using data on PWID in intimate partnerships in Almaty, Kazakhstan, this study performed latent class analysis (LCA) on drug and sexual risk behaviors and estimated associations between dyadic relationship factors and membership in latent classes.

Methods:

LCA was performed on a sample of 510 PWID (181-females/FWID, 321-males/MWID) to identify levels of drug and sexual risk behaviors. Generalized structural equation modeling with multinomial regressions estimated associations between relationship factors (length risk reduction communication, risk reduction self-efficacy) and class membership after adjusting for substance use severity, overdose, depression, binge drinking, intimate partner violence, structural factors, and sociodemographic characteristics. Models were sex-stratified to include FWID and PWID.

Results:

A 3-class model best fit the data and consisted of low, medium, and high-risk classes. GSEM found that greater injection self-efficacy was associated with a lower likelihood of membership in the high-risk class for PWID and FWID. For MWID, greater length of the relationship was associated with a lower likelihood of membership in the medium-risk class. Greater relationship communication was associated with increased risk of membership in the high-risk latent class for MWID.

Conclusions:

Future research must investigate if increasing risk reduction and safe sex self-efficacy could reduce drug and sexual risk behaviors and HIV transmission among PWID and their intimate partners. Interventions are needed that reduce power inequities within relationships as a method of increasing self-efficacy, particularly among women.

Keywords: People Who Inject Drugs, Injection Drug Use, Sexual Risks, Latent Class Analysis, Sexual Partnerships, Kazakhstan, Central Asia, Sex Differences

1. Introduction

Rates of HIV continue to grow among people who inject drugs (PWID) in Central Asia despite overall reductions worldwide in HIV incidence over the past decade (Degenhardt, 2016; Dehovitz et al., 2014; El-Bassel et al., 2013; Thorne et al., 2010). In Kazakhstan, HIV infection is expanding at a rate that is among the fastest in the world with an increase of 39% in new cases of HIV infections from 2010-2016 (UNAIDS, 2016). Kazakhstan has one of the highest rates of injection drug use in Eastern Europe and Central Asia (Vickerman et al., 2014) amounting to an estimated population of 120,500 in Kazakhstan (UNAIDS, 2016). Prevalence of HIV infection among PWID (8.5%) is 42.5 times greater than estimates of HIV prevalence in the general community (0.2%) (UNAIDS, 2016). High rates of injection drug risk behaviors have also led to widespread increases in HCV infection among PWID in Kazakhstan with estimates of HCV among PWID as high as 70.2% (Platt et al., 2017).

1.1. Drug and Alcohol Use in Kazakhstan

The risk environment conceptual framework organizes social determinants of sexual and drug risk behaviors into multiple levels that include: 1) individual, 2) intimate partnerships and other social relationships, and 3) structural (Rhodes, 2002; 2009). Individual factors include drug and alcohol use severity, which increases injection drug and sexual risk behaviors in Central Asia and other parts of the world (Azbel et al., 2015; El-Bassel et al., 2013a; 2013b; El-Bassel et al., 2014a; 2014b; 2014c; Marotta and El-Bassel, 2017). The rate of alcohol consumption in Kazakhstan is the highest in Central Asia with rates of alcohol use disorders of about 8% (WHO, 2015). Moreover, estimates of global lifetime prevalence of alcohol use disorders are as high as 60% amongst PWID (Azbel et al., 2015). In addition to substance use, mental health— and depression in particular— is closely associated with high-risk sexual and drug behaviors in Kazakhstan (Shaw et al., 2017a; Stein et al., 2003) and other countries (Armstrong et al., 2013; Brady et al., 2016; Ulibarri et al., 2015). Drug use patterns, particularly mixing opioids with ephedrine and sedatives prior to injection, increases risk of HIV transmission and overdose amongst PWID in Central Asia because it lowers inhibitions and impairs judgment to practice safe sex and injection drug risk behaviors (UNODC, 2008; Tavitian-Exley et al., 2015; Stone, 2016; Coffin, 2008).

1.2. Intimate Partnerships and HIV Risks Among PWID

Global research on HIV risks among PWID who are in intimate partnerships identify relationship variables including greater closeness, trust, and intimacy as determinants of greater risk of sexual and injection drug risk behaviors with primary partners (Ibanez et al., 2016; Jiwatram-Negrón et al., 2014; Syvertsen et al., 2013; 2014; 2015; Ullibari et al., 2015; Seear et al., 2012). Risk reduction communication within intimate partnerships, including discussing the need to use condoms, getting tested for HIV/HCV and other STI, alternatives to vaginal or anal sex (i.e., oral sex, masturbation), how to prevent HIV and STI, and making sex more fun may greatly reduce HIV transmission among PWID in Kazakhstan (El-Bassel, 2013a; 2013b; 2014). In addition to risk reduction communication, research suggests that belief in one’s capacity to insist on condom use, stop to look for condoms when sexually aroused, put condoms on intimate partners, and refuse to share syringes and other equipment with intimate partners protects against sexual and drug risk behaviors and HIV transmission among PWID and their intimate partners (El-Bassel et al., 2013; Gilbert et al., 2010; Jiwatran and El-Bassel, 2014). Gender inequalities perpetuate disparities in rates of sexual and drug risk behaviors as well as transmission of HIV (Blankenship et al., 2015; Rhodes, 2009; Marshall et al., 2004; Surrat et al., 2004). Experiencing intimate partner violence among FWID increases risky injection drug use and sexual behaviors, HIV transmission, and overdose (Gilbert et al., 2013; Marshall et al., 2008).

1.3. Structural Factors and HIV Risk Among PWID

Structural factors such as poverty and unemployment introduce barriers to adopting safe sex and injection drug practices among PWID and their intimate partners in Kazakhstan. The criminalization of drug use in Kazakhstan and throughout the world has led to heightened risk of HIV, HCV, and tuberculosis among PWID by virtue of overcrowding, poor sanitary conditions, lack of access to sterile syringes, and lack of access to or lapses in drug treatment (Altice et al., 2016; Azbel et al., 2015; 2016; Dolan et al., 2016; DeBeck et al., 2017; Jurgens, et al., 2011; Rubenstein et al., 2016).

1.4. The Need to Identify Profiles of Sexual and Drug Risks Among PWID in Kazakhstan

Research to identify typologies of drug and sexual HIV risk behaviors amongst PWID and their intimate partners is yet to occur in Kazakhstan or anywhere else in Central Asia despite a growth of studies identifying overlapping sexual and injection drug vulnerabilities to HIV infection experienced by PWID (El-Bassel, 2013; 2014; Syvertson, 2013). Studies that examine individual HIV risks do not adequately capture the intertwined nature of drug use and sexual risks within microsocial contexts of intimate partnerships amongst PWID leading to HIV prevention interventions that focus on only a single transmission pathway rather than multiple intersecting drivers of HIV. Third, few studies examine gender differences in subtypes of high-risk drug and sexual behaviors among PWID, which results in samples that rely upon findings from samples of predominantly MWID rather than FWID.

To address these gaps, we performed an exploratory latent class analysis (LCA) on drug and sexual HIV risk behaviors among PWID who are in intimate partnerships in Kazakhstan. After identifying if more than one underlying class fit the data, this study examined associations between relationship variables (relationship length, risk reduction self-efficacy, communication with partners) and membership in latent classes after adjusting for age, substance use (severity, overdose, problematic drinking), depression, intimate partner violence, and need for HIV counseling. All models examined gender differences in subtypes of high-risk drug and sexual behaviors and predictors of latent classes.

2. Methods

2.1. Study Population and Data Collection Procedures

This paper used a subset of data from Project Renaissance, a randomized controlled trial that evaluated the efficacy of a couples-focused behavioral HIV prevention intervention in which one or both partners reported recent injection drug use which was conducted between 2009-2012 (El-Bassel, 2014). Analyses presented herein utilized data from the baseline assessment. The Columbia University Institutional Review Board and the Kazakhstan School of Public Health Institutional Review Board approved the study protocol prior to conducting the research.

2.2. Eligibility Criteria and Recruitment

Syringe exchange programs, HIV treatment and prevention clinics, and outdoor locations provided settings to recruit eligible participants through word-of-mouth by way of injecting social network members and targeted outreach. PWID and their intimate partners were recruited if they 1)were older than 18 years old, 2) defined their heterosexual partners as a spouse, lover, boyfriend/girlfriend, or parent of his or her child, 3) reported the length of their relationship as greater than 6-months, 4) expressed intentions to remain in their intimate relationships for at least a year, and in the last 90 days at least one partner reported 5) engaging in unprotected sex (vaginal or anal) with the other partner. The sample for this study was the subset of 510 participants who reported engaging in injection drug use in the past 90 days.

2.2.1. Assessment.

Research assistants conducted pre and post-test counseling on HIV, HCV, and other STIs in a gender-specific room. All participants received post-test counseling that included notification of HIV, HCV, and STI test results within two weeks. Participants received compensation for completing the baseline assessment and biological testing of comparable value to about $10.

2.3. Measures

2.3.1. Biological Testing.

Biological assays tested for the presence of HIV, HCV, and STI (syphilis, gonorrhea, and chlamydia) using a dried blood spot technique (DBS) and were analyzed at the Republican AIDS Center (RAC) in Almaty, Kazakhstan. Cases of HIV and HCV were identified using a serial two-test strategy based on standards from the World Health Organization that used the Enzyme-Linked Immunosorbent Assay (ELISA) followed by the Abbott Murex Biotech test with a reported sensitivity of >99.99% and specificity of 99.99%. The measure for HCV infection reflects having ever been infected with HCV rather than active HCV infection.

2.3.2. Classification Indicators for Latent Class Analysis.

Classification indicators included 12 dichotomous items on unsafe injection behaviors, other drug use, and sexual risk in the past 90 days.

Unsafe injection behaviors encompassed: 1) receptive syringe or equipment sharing with others, 2) receptive syringe or equipment sharing with study partners, 3) syringe mediated sharing (drawing injection fluid from another syringe into the syringe for injection), 4) injecting drugs after someone squirted drugs into it from his or her syringe, 5) using a syringe prepackaged with heroin, 6) injecting drugs prepared using a common container, and 7) more than one injecting partner. Other drug use included: 8) drinking alcohol immediately prior to use of heroin and 9) mixing drugs with heroin when injecting. Sexual risk included 10) the classification indicator of never/ always engaging in condomless sex with primary intimate partners, given that the inclusion criteria included engaging in condomless sex in the past 90 days, 11) sex under the influence of drugs or alcohol with study partners, and 12) condomless sex with outside partners in the past 90 days.

2.3.3. Potential Predictors of Latent Class Membership.

Relationship length was measured by asking participants how long they were in intimate sexual relationships with study partners (years). Risk reduction communication included how many times PWID discussed 1) the need to use condoms, 2) getting tested for HIV/HCV or other STIs, 3) oral sex as an alternative to vaginal or anal sex, 4) masturbation as an alternative to vaginal or anal sex, 5) how to prevent HIV, 6) how to prevent STI, 7) making safe sex more fun, 8) discussing the need to stop sharing syringes, and 9) discussing the need to use new syringes with each new injection in the past 90 days (Gomez, 1996). Items measuring male condom use efficacy and risk reduction self-efficacy consisted of self-reported confidence with 1) discussing condom use with intimate partners, 2) insisting on condom use even if their partner does not want to use one, 3) stopping to look for condoms when sexually aroused, 4) insisting on condom use every time when the participant is under the influence of drugs or alcohol, 5) insisting on condom use every time even when the study partner is under the influence of drugs or alcohol, 6) putting a condom on study partner without spoiling the mood, 7) insisting on condom use even if partner uses other forms of contraception, and 8) refusing to share syringes even if their partner wants to use same needle (0 no, 1 probably no, 2 maybe, 3 probably yes, 4 definitely yes) (Deren and Kang, 2003; Kang and Deren, 2001; Windgood and DiClemente, 1998). All question items were dichotomized (1=yes) and summed with greater scores indicating more communication regarding risks between partners.

Drug Use Severity was measured with a scale summing the 9 question items of the Texas Christian University drug screen measured drug use severity (Institute of Behavioral Research, 2008; Knight et al., 2002). Opioid Overdose, a dichotomous variable, measured experiencing at least one opioid overdose in the past 6-months. Problem drinking was indicated if participants reported drinking 5 or more alcoholic beverages in a 6-hour period in the past 90 days. Depression: The Brief Symptom Inventory (BSI) is a 6-item scale measuring depression consisting of 1) thoughts of suicide, 2) feeling lonely even with other people, 3) feeling sad, 4) no interest in things, 5) hopelessness, and 6) worthlessness (alpha .85) (4 - extremely, 3 - quite a bit, 2 - moderately, 1 - a little bit, 0 - not at all) (Derogatis and Melisaratos, 1983). Intimate partner violence measured any physical, emotional, psychological, or sexual abuse from an intimate partner ever or in the past 6-months (1=Yes). Structural factor: Unmet need for HIV and STD counseling was measured by asking participants if in the past 6-months they needed HIV counseling or education. Poverty: participants whose self-reported income was less than 15,000 Tenge were classified as impoverished (El-Bassel, 2014). Criminal justice involvement included lifetime conviction for a drug crime (1=Yes). Appendix 1 1 shows Spearman rank correlation coefficients between classification indicators for the whole sample.

2.4. Data Analysis

Exploratory LCA involves fitting incrementally increasing models up to 5 and selecting the appropriate number of classes using the Bayesian Information Criterion (BIC), the sample size adjusted BIC, AIC, Lo-Mendel Rubin (LMR), the Bootstrapped Likelihood Ratio Test (BLRT), and Entropy (McCutcheon, 1987; Formann, 1984; Hagenaars and McCutcheon, 2002; Formann, 1984). This method is in contrast with LCA involving a priori hypothesis testing in which a predetermined number of classes are hypothesized and fit to the data in a single model. Exploratory LCA evaluated model fit statistics for the sample size adjusted SSBIC, BIC, and AIC and involved comparing test statistics from nested models and selection of the information criterion with the lowest number (Nylund et al., 2007; Jung and Wickrama, 2008). Model performance indicators for the bLRT tests the hypothesis that the model with one additional class is a significantly better fit than the model with one less class (Nylund et al., 2007; Muthén and Muthén, 2015). Latent class analyses were performed in Mplus, and posterior probabilities were imported into STATA for descriptive and multivariable regression analyses (Muthén and Muthén, 2015; Geiser, 2012; StataCorp, 2013). We performed gender-specific goodness of fit analyses to assess the data for differences in class membership between MWID and FWID.

In the overall models, a generalized structural equation model (GSEM) with a couple-level random coefficient accounted for the nominal outcome variable and dyadic, nested structure of the data (Gu et al., 2013; Rabe-Hesketh et al., 2002; Rabe-Hesketh and Skrondal, 2004). Given the nested structure of the data, a generalized structural equation model accounted for the shared variance of participants within couples. The structure of the data is individuals within partnerships (with all individuals nested within the same number of partnerships (2)). Dyadic data that is modeled at the individual level must be treated as nested data, and the shared variance between the 2nd order variable (couples) must be controlled to generate statistical inference at the individual-level. Paths from hypothesized covariates to latent classes estimated the effects of individual-level relationship variables (self-efficacy and communication) on sexual and drug risk behaviors with a random coefficient with the shared variance between couples to adjust for the dyadic structure of the data (StataCorp, 2013) (Figure 1). Two GSEM multinomial models were fit 1) with class 1 and 2) class 2 as reference categories. The unit of analysis for this study is at the individual-level rather than within couple measures. Parameter coefficients in the multinomial regression models were exponentiated from multinomial logits to relative risk ratios (RRR) and are presented with standard errors and p-values. Sex-stratified models examined differences in class membership for FWID and MWID with multinomial regression techniques using maximum likelihood (Long and Freese, 2006; Freese and Long, 2000; Hamilton and Seyfrit, 1993).

Figure 1.

Figure 1.

Full two-level generalized structural equation multinomial regression model with shared couple-level random effects used in overall models of predictors of class membership for the whole sample.

Notes: TCU=Texas Christian University Scale; Depression=Brief Symptom Inventory; Risk classes are factor variables of membership in classes 3 and 2 versus class 1.

Sensitivity analysis on data from the parent study found participants who did not engage in injection drug use in the past 90 days (n=218) were similar to PWID on all of the relationship variables (length, self-efficacy, and communication) as well as binge drinking, needing HIV/STI counseling, IPV, age, and poverty (See appendix 2)2. The proportion of participants infected with HIV, HCV, and HIV/HCV co-infection, as well as overdose and prior drug crime conviction, were higher among PWID. Scores on the depression and drug use severity scales were higher for PWID compared to non-PWID.

3. Results

3.1. Goodness of Fit Statistics

Goodness of fit values is presented in Table 1 for the AIC, BIC, BICa, and bLRT information criteria as well as the LMR test statistic. The values for the BIC increased in class 4 over class 3 supporting the selection of the three-class model. The improvement provided by the four- compared to the three-class models was not statistically significant (p<.05) using the bLRT and LMR, lending further support for the selection of the 3-class model. Goodness of fit statistics in the models stratified by sex closely mirrored findings in the overall model, suggesting a similar number of latent classes underlying sexual and drug risk behaviors for FWID and MWID.

Table 1.

Goodness of fit statistics.

PWID FWID MWID
2-class 3-class 4-class 5-class 2-class 3-class 4-class 5-class 2-class 3-class 4-class 5-class
AIC 6432.20 6291.63 6275.91 6266.38 2320.40 2293.34 2294.35 2296.07 3830.53 3728.67 3716.73 3720.47
BIC 6538.06 6452.54 6491.87 6537.38 2401.44 2416.53 2448.48 2493.54 3924.82 3871.98 3909.07 3961.84
BICa 6458.70 6331.91 6329.99 6334.24 2322.25 2296.17 2290.94 2290.82 3845.52 3751.45 3755.31 3758.84
Ent .85 .83 .83 .79 0.84 .89 .89 .90 0.84 0.83 0.84 0.83
bLRT p<.001 p<.001 p=.07 0.41 p<.001 0.025 0.26 0.17 p<.001 p<.001 0.40 0.07
LMR p<.001 p<.001 p=.06 0.42 p<.001 0.03 0.26 0.17 p<.001 p<.001 0.41 0.07

3.2. Latent Class Probability and Class Description

The first risk class accounted for nearly a quarter (.23, n=119) of the sample of PWID (Table 2). More than a third (.38, n=193) were in the second risk class, and the remaining participants (.39, n=198) were in the third risk class. In the first risk class, the probability of endorsing all of the injection drug risk variables was low with a high probability of unprotected sex with study partners. We named this class “low-risk.” Members of the second class had a high probability of syringe-mediated sharing and sharing using a common container alongside a high probability of unprotected sex with intimate partners. We named this class “medium-risk.” In support of the hypothesis of the number of classes, the third risk class exhibited a high probability on all classification items with the exception of unprotected sex with non-intimate partners. We labeled class 3 “high-risk.”

Table 2.

Probability of class membership for HIV injection and sexual risk classification indicators.

Overall FWID MWID
Low-risk Medium Risk High Risk Low-risk Medium Risk High Risk Low-risk Medium Risk High Risk
Class counts and proportions1 119(.23) 193(.38) 198(.39) 34(.18) 73(.39) 82(.43) 91(.28) 130(.40) 100(.31)
Classification indicators
1 RSES others .08(.03) .28(.11) .99(.05) .15(.07) .20(.08) 1(0) .06(.03) .38(.18) 1(0)
2 RSES study partners .07(.03) .28(.07) .64(.05) .07(.05) .38(.06) .72(.05) .06(.03) .26(.75) .59(.06)
3 Front or back loading .03(.04) .86(.06) .99(.008) 0(0) .79(.06) .99(.01) .05(.04) .92(.06) 1(0)
4 Squirt inject fluid .06(.02) .09(.05) .75(.09) .12(.06) .10(.04) .77(.07) .04(.02) .11(.05) .79(.18)
5 Prepack injection solution .07(.03) .20(.05) .51(.05) .12(.88) .18(.05) .48(.07) .06(.03) .23(.04) .55(.11)
6 Sharing common container .02(.06) .89(.04) .99(.01) 0(0) .85(.05) 1(0) .05(.03) .93(.04) .98(.02)
7 Multiple injection partners .03(.03) .16(.07) .66(.06) .09(.05) .16(.05) .66(.07) .02(.02) .18(.10) .69(.08)
8 Drink before using heroin .39(.05) .58(.04) .76(.04) .28(.09) .51(.49) .70(.06) .23(.05) .62(.06) .82(.11)
9 Mixed drugs with heroin .23(.04) .41(.05) .54(.04) .26(.09) .40(.06) .54(.06) .44(.06) .42(.05) .55(.08)
10 No condom use with partner .68(.05) .65(.05) .70(.05) .83(.07) .79(.05) .95(.03) .87(.04) .93(.03) .87(.04)
11 Sex drugs/alcohol .76(.04) .90(.03) .93(.02) .72(.08) .87(.04) .94(.03) .77(.05) .94(.03) .91(.04)
12 Unprotected sex with others .08(.04) .08(.03) .22(.04) .06(.04) 0(0) .15(.04) .10(.04) .12(.04) .27(.08)
1

Past 90 days

3.3. Descriptive Analyses of Independent Variables and Latent Classes of Sexual and Drug Risks

Table 3 presents means (M) with standard errors (SE) and proportions for the predictors of class membership as well as bivariate tests of significance of differences between FWID and MWID.

Table 3.

Descriptive statistics of relationship factors, HIV/HCV infection, substance use, mental health trauma, structural and sociodemographic characteristics for FWID and MWID and overall (PWID).

PWID MWID FWID p-value
Relationship Factors
 Relationship Length Mean(SD) 5.19(.27) 5.47(.46) 5.02(.33) 0.215
 Communication Mean(SD) 2.27(.18) 2.02(.13) 2.70(.18) <.001
 Self-efficacy Mean(SD) 20.15(.62) 20.50(.52) 20.15(.62) 0.334
HIV/HCV cases
 HIV %(n) 29.02(148) 28.97(.93) 29.02(148) 0.97
 HCV %(n) 91.18(465) 90.97(292) 91.53(173) 0.827
 HCV/HIV %(n) 25.88(132) 26.48(85) 24.87(47) 0.688
Substance use
 TCU-II Scale Mean(SD) 7.18(.09) 7.14(.11) 7.25(.15) 0.277
 Overdose %(n) 22.16(113) 21.50(69) 23.28(44) .639
 Problem drinking %(n) 68.43(349) 73.52(236) 59.79(113) <.001
Mental health/Trauma
 Depression Mean(SD) 7.05(.25) 6.08(.30) 8.70(.42) <.001
 IPV %(n) 18.04(92) 19.31(62) 15.87(30) 0.329
Unmet service needs
 HIV/STD %(n) 55.29(282) 52.65(169) 59.79(113) 0.117
Sociodemographic
 Age Mean(SD) 36.42(.51) 36.80(.42) 35.79(.51) 0.07
Structural conditions
 Poverty %(n) 40.59(207) 35.83(115) 48.68(92) 0.004
 Drug crime %(n) 73.92(377) 75.39(242) 71.43(135) 0.325

On average, PWID in the highest risk class was in relationships with their intimate partners for shorter periods of time (M=4.57 SE=.42) compared to the low-risk class (M=6.36, SE=.62, p<.01) (Table 4). Relationship risk reduction self-efficacy was significantly lower in the high-risk (19.28, SE=8.91) compared to the low-risk class (20.49, SE=.89, p<.05). Risk reduction communication was higher in the high (M=2.65, SE=.18) than the medium (M=2.38, SE=.17, p<.05) and low-risk classes (M=1.48, SE=.18, p<.001).

Table 4.

Differences between latent classes and sociodemographic, drug use, service utilization and structural factors for PWID (n=510).

Class 1 (119) Class 2 (193) Class 3 (198)
p-value %(n) p-value
2 vs 1 3 vs 1 3 vs 2
Relationship factors M(SE)
 Length 6.36(.62) 5.10(.41) 0.096 4.57(.42) 0.014 0.356
 Self-Efficacy 20.49(.89) 21.42(.61) 0.425 19.28(.63) 0.249 0.019
 Communication 1.48(.18) 2.38(.17) 0.041 2.65(.18) 0.002 0.145
HIV/HCV %(n)
 HIV 31.93(38) 30.57(59) .784 25.76(51) .267 .784
 HCV 87.39(104) 90.67(175) .348 93.94(186) .055 .288
 HCV/HIV 26.05(31) 26.42(51) .948 25.25(50) .886 .831
Substance use
 TCU-II Scale M(SE) 6.38(.20) 7.17(.13) .004 7.68(.14) <.001 .017
 Problem drinking %(n) 57.98(69) 65.80(127) .144 77.27(153) <.001 .015
Overdose
 Lifetime 63.03(75) 68.91(133) .218 78.79(156) .003 .045
 Recent 13.45(16) 16.58(32) .382 32.83(65) <.001 .001
 Depression M(SD) 5.50(.25) 6.62(.38) .060 8.41(.42) <.001 .004
Intimate partner Violence %(n)
 Lifetime 40.34(48) 51.30(99) .058 59.60(118) .002 .172
 Recent 9.24(11) 16.06(31) .082 25.25(50) .001 .049
Unmet service needs %(n)
 HIV/STD 40.34(48) 55.96(108) .009 63.64(126) <.001 .167
Structural conditions %(n)
 Poverty 41.18(49) 34.72(67) .260 45.96(91) .504 .037
 Drug crime 68.07(81) 72.54(140) .416 78.79(156) .047 .140
Sociodemographic
 Female %(n) 27.73(33) 38.86(75) .044 40.91(81) .019 .858
 Age M(SE) 37.88(.73) 37.03(.54) .272 34.95(.46) .001 .012

Tests of differences performed using unadjusted multinomial regression with generalized structural equation modeling with couple level random effects comparing membership in latent classes

3.4. Multivariate Regressions

FWID were more likely than MWID to be in the medium-risk class (RRR=1.71, SE=.48, p<.05) than low-risk class (Table 4). Greater age was associated with a lower likelihood of membership in the high- compared to the medium- (RRR=.95 SE=.02, p<.05) and low-risk class (RRR=.96 SE=.02, p<.05). For MWID, individuals in the high-risk (RRR=.94, SE=.02, p<.01) class were younger compared to the medium-risk class.

3.4.1. Relationship Context.

Overall greater relationship risk reduction self-efficacy was associated with lower likelihood of class membership in the high- (RRR=.96, SE=.02, p<.01) and medium-risk classes (RRR=.95, SE=.02. p<.05) compared to the low-risk class. Greater communication about risk reduction was associated with a greater likelihood of membership in the high- (RRR=1.32, SE=.10, p<.001) and medium-risk classes (RRR=1.21, SE=.08). For FWID, higher self-efficacy for negotiating safe sex and injection behaviors was associated with a lower likelihood of membership in the high- (RRR=.91, SE=.03, p<.001) and medium-risk classes (RRR=.92, SE=.02, p<.001). For MWID, greater relationship length was associated with lower likelihood of membership in the medium- (RRR=.94, SE=.02, p<.01) compared to low-risk class. MWID who engaged in communication about risk reduction with partners were more likely to be in the high- compared to low-risk class (RRR=1.26, SE=.10, p<.001).

3.4.2. Substance Use.

Severity of drug use was associated with a greater probability of membership in the high (RRR=1.31, SE=.11 p<.001) and medium-risk classes (RRR=1.16, SD=.07, p<.05) compared to the low-risk class. Problem drinking was associated with a greater probability of membership in the high (RRR=3.13 SE=1.08 p<.05) compared to the low HIV risk behavior class. Greater drug use severity was associated with membership in the high-risk class for FWID (RRR=1.48, SE=.20, p<.01) and MWID (RRR=1.32, SE .14, p<.05). FWID with severe drug use were more likely to be in the medium- (RRR=1.27, SE=.14, p<.05) than low-risk class. Problem drinking was associated with increased risk of membership in the high- (RRR=5.80, SE=3.00, p<.01) and medium-risk classes for FWID (RRR=3.02, SE=1.26, p<.01).

3.4.3. Mental Health.

Self-reported symptoms of depression were significantly associated with membership in the high- compared to low-risk class (RRR=1.08 SE=1.04, p=.05).

3.4.4. Structural Factors.

Need for HIV/STD counseling was associated with increased likelihood of membership in medium- (RRR=1.91 SE=.47, p<.01) and high-risk classes of HIV risk behaviors (RRR=2.85, SE=.92, p<.01). When stratified by sex, the self-reported need for HIV and STI counseling was associated with membership in the high- (RRR=3.06, SE=1.00, p<.001) and medium- (RRR=2.40, SE=.90, p<.05) compared to low-risk categories for MWID. For FWID, poverty (RRR=2.40, SE =.90, p<.05) was associated with increased risk of membership in the high-risk class for the high compared to medium-risk class.

4. Discussion

This paper addresses a significant gap in the literature by applying LCA to identify clusters of high-risk sexual and drug-related behaviors among PWID in Kazakhstan. Overall, nearly a quarter of the sample were in the low-risk class characterized by unprotected sex and sex under the influence of drugs and alcohol but low probability of injection drug risk behaviors, illicit drug use, drug mixing, and risky sexual behaviors. A medium-risk class (class 2) consisted of sexual risk behaviors with intimate partners, front or backloading, sharing a common container, and drinking alcohol immediately before using heroin. The high-risk class consisted of a high probability of receptive syringe sharing with study partners and others, front or backloading, squirting injection drug fluid, sharing a common container, multiple injection partners, drinking alcohol immediately prior to using heroin, sex under the influence of drugs and alcohol, and unprotected sexual behaviors with primary partners.

Members of the medium-risk class were more likely to be female compared to those of the low-risk class. Additionally, participants who were in the high-risk class were younger compared to the low-risk class. epressive symptoms were related to greater likelihood of class membership in the high-risk class of drug and sexual behaviors. Prior literature on single risk factors supports these findings in Kazakhstan (Shaw, 2017) and other parts of the world (Armstrong et al., 2013; Ulibarri et al., 2015). Members of the high and medium-risk classes were more likely to report severe substance use problems compared to the low-risk class for the overall sample.

Greater safe sex and injection drug self-efficacy was a protective factor against membership in the high-risk sexual and drug behavior class for FWID. Greater length of time in intimate partnerships was associated with a lower likelihood of membership in the medium-risk class compared to partnerships for less time for MWID. Greater scores on relationship risk reduction self-efficacy predicted lower risk of membership in the high-risk (class 3) compared to the low-risk (class 1) classes of drug and sexual risk behaviors. Surprisingly, greater communication with partners about risk reduction was associated with a greater risk of membership in the highest risk class. PWID who are engaged in more risk behaviors may have more opportunities to discuss them with their partners compared to other classes, which by definition would afford greater opportunities for discussing risk reduction.

4.1. Implications for HIV Prevention and Substance Use Treatment with PWID Who Are in Intimate Sex Partnerships

Prevention programs for PWID must address multiple domains of risk behaviors simultaneously within the contexts of intimate partnerships. It is critical that evidence-based HIV prevention programs integrate effective drug and sexual risk reduction interventions such as multi-level HIV/STI prevention strategies, HIV/STI testing and counseling, and PrEP alongside the provision of condoms, sterile syringes, and injection equipment. Targeted HIV prevention programs must incorporate interventions that combine evidence-based principles to address the comprehensive service needs presented by PWID. Risk reduction interventions must encourage PWID and their intimate partners to engage in safer sexual and injection drug risk behaviors within a single package of evidence-based interventions. Gender inequities in relationships may erode self-efficacy of FWID to insist on safe sexual and drug practices within micro-social contexts of intimate partnerships in Kazakhstan. Future research is necessary among couples who use drugs to further explore relationships between gender inequities and relationship factors among PWID and their intimate partners in Kazakhstan.

4.2. Limitations

Several limitations warrant elucidation. First, the data are cross-sectional and thus precludes temporal ordering and causal inference of findings from regressions between predictor variables and HIV risk classes. Second, self-report bias may lead to underestimation of engagement in drug and sexual risk behaviors. Third, although the study is with participants in a couples-focused HIV prevention intervention, the data is at the individual and not the dyadic level. Not all participants engaged in injection drug use in the past 90 days, which includes several of the classification indicators restricting the data to a subset of participants in the Project Renaissance sample. Given the individual-level data, it is not possible to generalize to the couple-level. Statistical inference at the couple-level would lead to an ecological fallacy about the behaviors of dyads of PWID. Future inquiry must extend beyond individual-level research to explore dyadic data analyses accounting for both partners’ behaviors. Research studies are needed that elucidate the influence of partners’ relationship self-efficacy and communication, drug use severity, and other factors on latent classes of injection drug and sexual risk behaviors among PWID. Future research is needed that examines within-partnership/couple measures such as values summed across partner values for injection drug risk behaviors with intimate partners. Fourth, a statistical limitation of the LCA technique used in this study assumes the 12 drug and sexual HIV transmission risk classification indicators are locally independent when conditioned on the latent construct of risk. Finally, sensitivity analysis suggested that restricting the sample to only PWID resulted in some selection bias in which PWID with more severe substance use profiles and HIV needs were included in the analysis.

5. Conclusion

Limitations notwithstanding, each of the identified subtypes of drug and sexual risk behaviors informs different strategies and avenues for HIV prevention with PWID in Kazakhstan. The low-risk category class may benefit from interventions that focus primarily on sexual risk behaviors with less focus on drug-related risks. The medium-risk class might benefit from the provision of sterile injection equipment and education surrounding the risks presented by sharing equipment. The highest risk group requires HIV prevention programs that target the overlap between several drugs and sexual risk behaviors. Future research must focus on these relationships longitudinally to identify how these subtypes of risks change over time. Findings from this paper emphasize the heterogeneity of HIV risk behaviors among PWID in Kazakhstan. Increasing coverage and uptake of HIV prevention programs must acknowledge the intertwined nature of drug use and sexual risks in intimate partnerships driving HIV/HCV infection and overdose in Kazakhstan.

Supplementary Material

1

Table 5.

Adjusted Relative Risk Ratios from multinomial regression models predicting latent class membership.

PWIDa FWIDb MWIDb
2 vs. 1 3 vs. 1 3 vs 2 2 vs. 1 3 vs. 1 3 vs 2 2 vs. 1 3 vs. 1 3 vs 2
RRR(SD) RRR(SD) RRR(SD) RRR(SD) RRR(SD) RRR(SD) RRR(SD) RRR(SD) RRR(SD)
Relationship factors
  Length .97(.02) .99(.03) 1.01(.03) 1.02(.03) 1.02(.03) 1.01(.03) .94(.02)* .98(.03) 1.03(.03)
  Self-Efficacy .99(.01) .96(.02)** .96(.03)** .99(.03) .91(.03)*** .92(.02)*** .99(.02) .98(.02) .98(.02)
  Communication 1.21(.08)** 1.32(.10)*** 1.09(.06) 1.19(.14) 1.27(.18)+ 1.06(.08) 1.14(.09)+ 1.26(.10)*** 1.10(.07)
Sociodemographic
  Female sex 1.71(48)* 1.40(.45) .83(.23)
  Age 1.01(.02) .96(.02)* .95(.02)* .98(.03) .94(.04)+ .96(.03) 1.03(.02) .97(.02) .94(.02)**
Substance use
  TCU-Score 1.16(.07)* 1.31(.11)*** 1.13(.09) 1.27(.14)* 1.48(.20)** 1.18(.13) 1.14(.08)+ 1.32(.14)* 1.17(.11)
  Overdose 1.19(.32) 1.59(.52) 1.35(.41) .77(.38) 1.53(.92) 1.97(.98) 1.49(.49) 1.46(.51) .98(.32)
  Problem Drinking 1.47(.50)1.62(.45)+ 3.13(1.08)** 1.92(.62)* 1.47(.50)1.91(.89) 5.80(3.00)** 3.02(1.26)** 1.47(.50) 1.92(.75)+ 1.31(.43)
Mental health/IPV
  Depression 1.01(.03) 1.08(.04)* 1.06(.03) 1.01(.05) 1.07(.05) 1.06(.04)+ 1.01(.03) 1.03(.03) 1.02(.03)
  IPV 1.10(.29) 1.18(.36) 1.08(.280 1.05(.48) .65(.36) .65(.28) 1.17(.36) 1.26(.42) 1.07(.30)
Unmet service needs
  HIV/STD 1.91(.47)** 2.85(.92)** 1.50(.42) 1.60(.73) 2.06(1.03) 1.29(.51) 2.50(.74)** 3.06(1.00)*** 1.22(.35)
Structural conditions
  Poverty .65(.16) 1.02(.30) 1.55(.39)+ .90(.42) 2.18(1.12) 2.40(.90)* .58(.18)+ .94(.33) 1.64(.49)
  Drug conviction 1.05(.33) 1.64(.61) 1.54(.51) 1.84(.86) 2.16(1.24) 1.17(.58) .87(.31) 1.13(.46) 1.30(.47)
***

<p<.001

**

p<.01

*

p<.05

p<.10 in bold

a

modeled using generalized structural equation modeling with couple level random effects (n=510)

b

Modeled using polytomous regression with maximum likelihood

Highlights.

  • Latent class analysis on sexual and drug HIV risks among PWID in Kazakhstan.

  • Identified 3 underlying latent classes of low, medium, and high HIV risk behavior.

  • Similar latent class structure between men, women and overall.

  • Shorter relationship length associated with medium-risk class membership for men.

  • Low risk reduction self-efficacy associated with high/medium class for women.

Acknowledgments

Role of Funding Source

Funding for the parent study was provided by R01 DA022914-01 to Nabila El-Bassel, Research for this paper was funded by a F31 grant to #DA044794 to Phillip L. Marotta.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest

No conflict declared.

References

  1. Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R, 2016. The perfect storm: Incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet 388, 1228–1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armstrong G, Jorm AF, Samson L, Joubert L, Nuken A, Singh S, Kermode M, 2013. Association of depression, anxiety, and suicidal ideation with high-risk behaviors among men who inject drugs in Delhi, India. J. Acquir. Immune Defic. Syndr 64, 502–510. [DOI] [PubMed] [Google Scholar]
  3. Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, Dvoryak S, Rotberga S, Altice FL, 2015. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug Alcohol Depend. 151, 68–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Azbel L, Polonsky M, Wegman M, Shumskaya N, Kurmanalieva A, Asanov A, Wickersham JA, Dvoriak S, Altice FL, 2016. Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment. Int. J. Drug Policy 37, 9–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bailey H, Turkova A, Thorne C, 2017. Syphilis, hepatitis C and HIV in Eastern Europe. Curr. Opin. Infect. Dis 30, 93–100. [DOI] [PubMed] [Google Scholar]
  6. Blankenship KM, Reinhard, Sherman SG, El-Bassel N, 2015. Structural interventions for HIV prevention among women who use drugs: A global perspective. J. Acquir. Immune Defic. Syndr 69, S140–S145. [DOI] [PubMed] [Google Scholar]
  7. Brady SS, Gruber SK, Wolfson JA, 2016. Positive and negative aspects of relationship quality and unprotected sex among young women. Sex Educ. 16, 586–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burton J, Darbes LA, Operario D, 2010. Couples-focused behavioral interventions for prevention of HIV: Systematic review of the state of evidence. AIDS Behav. 14, 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coffin P, 2008. Overdose: A major cause of preventable death in Central and Eastern Europe in Central Asia recommendations and overview of the situation in Latvia, Kyrgyzstan, Romania, Russia and Tajikistan, Eurasian Harm Reduction Network (EHRN), Vilnius. https://www.opensocietyfoundations.org/sites/default/files/overdose_20080801.pdf.
  10. Collins LM, Lanza ST, 2013. Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences. John Wiley and Sons, Hoboken, NJ. [Google Scholar]
  11. Corbett AM, Dickson-Gómez J, Hilario H, Weeks MR, 2009. A little thing called love: Condom use in high-risk primary heterosexual relationships. Perspect. Sex Reprod. Health 41, 218–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DeBeck K, Cheng T, Montaner JS, Beyrer, Elliott R, Sherman S, Wood E, Baral S, 2017. HIV and the criminalisation of drug use among people who inject drugs: A systematic review. Lancet HIV 4, e357–e374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, 2016. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: Findings from the Global Burden of Disease Study 2013. Lancet Infect. Dis 16, 1385–1398. [DOI] [PubMed] [Google Scholar]
  14. DeHovitz J, Uuskula, El-Bassel N, 2014. The HIV epidemic in Eastern Europe and Central Asia. Curr. HIV/AIDS Rep 11, 168–176. [DOI] [PubMed] [Google Scholar]
  15. Deren S, Kang S-Y, Rapkin B, Robles RR, Andia JF, Colón HM, 2003. The utility of the PRECEDE model in predicting HIV risk behaviors among Puerto Rican injection drug users. AIDS Behav. 7, 405–412. [DOI] [PubMed] [Google Scholar]
  16. Derogatis LR, Melisaratos N, 1983. The brief symptom inventory: An introductory report. Psychol. Med 13, 595–605. [PubMed] [Google Scholar]
  17. Des Jarlais DC, Boltaev A, Feelemyer J, Bramson H, Arasteh K, Phillips BW, Hagan H, 2013. Gender disparities in HIV infection among persons who inject drugs in Central Asia: A systematic review and meta-analysis. Drug Alcohol Depend. 132, S7–S12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, 2016. HIV and related infections in prisoners 1. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet 388, 1089–1102. [DOI] [PubMed] [Google Scholar]
  19. El-Bassel N, Gilbert L, Terlikbayeva A, Wu E, Beyrer C, Shaw S, Hunt T, Ma X, Chang M, Ismayilova L, 2013a. HIV among injection drug users and their intimate partners in Almaty, Kazakhstan. AIDS Behav. 17, 2490–2500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. El-Bassel N, Strathdee SA, El Sadr WM, 2013b. HIV and people who use drugs in central Asia: Confronting the perfect storm. Drug Alcohol Depend. 132, S2–S6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. El-Bassel N, Gilbert L, Terlikbayeva A, Beyrer C, Wu E, Chang M, Hunt T, Ismayilova L, Shaw SA, Primbetova S, 2014a. Effects of a couple-based intervention to reduce risks for HIV, HCV, and STIs among drug-involved heterosexual couples in Kazakhstan: A randomized controlled trial. J. Acquir. Immune Defic. Syndr 67, 196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. El-Bassel N, Gilbert L, Terlikbayeva A, Beyrer C, Wu E, Shaw SA, Ma X, Chang M, Hunt, Ismayilova L, 2014b. HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: Implications for HIV prevention, research, and policy. Int. J. Drug Policy 25, 1195–1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA, 2014c. People who inject drugs in intimate relationships: It takes two to combat HIV. Curr. HIV/AIDS Rep 11, 45–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Freese J, Long JS, 2000. Tests for the multinomial logit model. Stata J. 10 http://www.indiana.edu/~jslsoc/files_research/reprints/STBmlogtest.pdf [Google Scholar]
  25. Geiser C, 2012. Data analysis with Mplus. Guilford Press, New York. [Google Scholar]
  26. Gilbert L, El-Bassel N, Terlikbayeva A, Rozental Y, Chang M, Brisson A, Wu E, Bakpayev M, 2010. Couple-based HIV prevention for injecting drug users in Kazakhstan: A pilot intervention study. J. Prev. Interv. Community 38, 162–176. [DOI] [PubMed] [Google Scholar]
  27. Gilbert L, Primbetova S, Nikitin D, Hunt T, Terlikbayeva A, Momenghalibaf A, Ruziev M, El-Bassel N, 2013. Redressing the epidemics of opioid overdose and HIV among people who inject drugs in Central Asia: The need for a syndemic approach. Drug Alcohol Depend. 132, S56–S60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gómez CA, Marin BV, 1996. Gender, culture, and power: Barriers to HIV-prevention strategies for women. J. Sex Res 33, 355–362. [Google Scholar]
  29. Gu Y, Hole AR, Knox S, 2013. Fitting the generalized multinomial logit model in Stata. Stata J. 13, 382–397. https://www.stata-journal.com/sjpdf.html?articlenum=st0301 [Google Scholar]
  30. Hagenaars JA, McCutcheon AL, 2002. Applied latent class analysis. Cambridge University Press, Cambridge. doi: 10.1017/CBO9780511499531 [DOI] [Google Scholar]
  31. Hamilton LC, Seyfrit CL, 1993. Interpreting multinomial logistic regression. Stata J. [Google Scholar]
  32. Ibañez GE, Whitt E, Avent T, Martin SS, Varga LM, Cano MA, O’Connell DJ, 2017. ‘Love and trust, you can be blinded’: HIV risk within relationships among Latina women in Miami, Florida. Ethn. Health 22, 510–527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Institute of Behavioral Research, 2008. Texas Christian University Drug Screen II Institute of Behavioral Research. Available at https://ibr.tcu.edu/forms/tcu-drug-screen/. [Google Scholar]
  34. Jiwatram-Negrón T, El-Bassel N, 2014. Systematic review of couple-based HIV intervention and prevention studies: Advantages, gaps, and future directions. AIDS Behav. 18, 1864–1887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Jung T, Wickrama K, 2008. An introduction to latent class growth analysis and growth mixture modeling. Soc. Personal. Psychol. Compass 2, 302–317. [Google Scholar]
  36. Jürgens R, Nowak M, and Day M, 2011. HIV and incarceration: Prisons and detention. J. Int. AIDS Soc 14, 26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kang S-Y, Deren S, Andia J, Colón HM, Robles R, 2001. Gender differences in HIV risk behaviors among Puerto Rican drug injectors by awareness of HIV seropositive status. AIDS Behav. 5, 241–249. [Google Scholar]
  38. Kazakhstan Ministry of Health Republican Center on Prevention and Control of AIDS, 2016. The number of people who inject drugs (IDUs) in Kazakhstan, Almaty. Available to http://www.rcaids.kz/en/. [Google Scholar]
  39. Knight K, Simpson DD, Morey JT, 2002. An evaluation of the TCU Drug Screen National Institute of Justice, Office of Justice Programs, US Department of Justice, Washington, DC: Available at https://www.ncjrs.gov/pdffiles1/nij/grants/196682.pdf. [Google Scholar]
  40. Long JS, Freese J, 2006. Regression models for categorical dependent variables using Stata. Stata Press, Texas. [Google Scholar]
  41. Marshall BD, Fairbairn N, Li K, Wood E, Kerr T, 2008. Physical violence among a prospective cohort of injection drug users: A gender-focused approach. Drug Alcohol Depend. 97, 237–246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. McCutcheon AL, 1987. Latent class analysis. Sage Publications, Thousand Oaks, CA. [Google Scholar]
  43. Muthén LK, Muthén BO, 2015. Mplus User’s Guide. Seventh Edition. Muthén and Muthén, Los Angeles, CA. [Google Scholar]
  44. Nylund KL, Asparouhov T, Muthén BO, 2007. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct. Equ. Modeling 14, 535–569. [Google Scholar]
  45. Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, Yanny I, Razavi H, Vickerman P, 2016. Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. Lancet Infect. Dis 16, 797–808. [DOI] [PubMed] [Google Scholar]
  46. Rabe-Hesketh S, Skrondal A, 2008. Multilevel and longitudinal modeling using Stata, 2nd ed. Stata Press, Texas. [Google Scholar]
  47. Rabe-Hesketh S, Skrondal A, Pickles A, 2002. Reliable estimation of generalized linear mixed models using adaptive quadrature. Stata J. 2, 1–21. [Google Scholar]
  48. Rhodes T, 2002. The‘risk environment’: A framework for understanding and reducing drug-related harm. Int. J. Drug Policy 13, 85–94. [Google Scholar]
  49. Rhodes T, 2009. Risk environments and drug harms: A social science for harm reduction approach. Int. J. Drug Policy 20, 193–201. [DOI] [PubMed] [Google Scholar]
  50. Rubenstein LS, Amon JJ, McLemore M, Eba P, Dolan K, Lines R, Beyrer C, 2016. HIV, prisoners, and human rights. Lancet 388, 1202–1214. [DOI] [PubMed] [Google Scholar]
  51. Seear K, Gray R, Fraser S, Treloar C, Bryant J, Brener L, 2012. Rethinking safety and fidelity: The role of love and intimacy in hepatitis C transmission and prevention. Health Sociol. Rev 21, 272–286. [Google Scholar]
  52. Shaw SA, El-Bassel N, Gilbert L, Terlikbayeva A, Hunt T, Primbetova S, Rozental Y, Chang M, 2016a. Depression among people who inject drugs and their intimate partners in Kazakhstan. Community Ment. Health J 52, 1047–1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Shaw SA, Terlikbayeva A, Famouri L, Hunt T, Gilbert L, Rozental Y, Primbetova S, Chang M, Ma X, El-Bassel N, 2016b. HIV testing and access to HIV medical care among people who inject drugs and their intimate partners in Kazakhstan. J. Subst. Use 22, 53–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Stata LP, 2013. Multilevel mixed-effects Reference manual. StataCorp LP, College Station, TX. [Google Scholar]
  55. Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I, 2003. Depression severity and drug injection HIV risk behaviors. Am. J. Psychiatry 160, 1659–1662. [DOI] [PubMed] [Google Scholar]
  56. Stone K, 2016. The global state of harm reduction 2016. Harm Reduction International, London: Available at https://www.hri.global/files/2016/11/14/GSHR2016_14nov.pdf [Google Scholar]
  57. Surratt HL., Inciardi JA., Kurtz SP, and Kiley MC, 2004. Sex work and drug use in a subculture of violence. Crime Delinq. 50, 43–59. [Google Scholar]
  58. Syvertsen JL, Robertson AM, Palinkas LA, Rangel MG, Martinez G, Strathdee SA, 2013. 'Where sex ends and emotions begin': Love and HIV risk among female sex workers and their intimate, non-commercial partners along the Mexico-US border. Cult. Health Sex 15, 540–554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Syvertsen JL, Robertson AM, Strathdee SA, Martinez G, Rangel MG, Wagner KD, 2014. Rethinking risk: Gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border. Int. J. Drug Policy 25, 836–844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Syvertsen JL, Bazzi AR, Martinez G, Rangel MG, Ulibarri MD, Fergus KB, Amaro H, Strathdee SA, 2015. Love, trust, and HIV risk among female sex workers and their intimate male partners. Am. J. Public Health 105, 1667–1674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Tavitian-Exley I, Vickerman P, Bastos FI, Boily MC, 2015. Influence of different drugs on HIV risk in people who inject: Systematic review and meta-analysis. Addiction 110, 572–584. [DOI] [PubMed] [Google Scholar]
  62. Thorne C, Ferencic N, Malyuta R, Mimica J, Niemiec T, 2010. Central Asia: Hotspot in the worldwide HIV epidemic. Lancet Infect. Dis 10, 479–488. [DOI] [PubMed] [Google Scholar]
  63. Ulibarri MD, Roesch S, Rangel MG, Staines H, Amaro H, and Strathdee A, 2015. “Amar te duele”(“love hurts”): Sexual relationship power, intimate partner violence, depression symptoms and HIV risk among female sex workers who use drugs and their non-commercial, steady partners in Mexico. AIDS Behav. 19, 9–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. UNAIDS, 2016. Country Profile: Kazakhstan. Available at http://www.unaids.org/.
  65. United Nations Office on Drugs and Crime, 2008. World Drug Report. United Nations Office on Drugs and Crime, Vienna: Available at https://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf. [Google Scholar]
  66. Wingood GM, DiClemente RJ, 1998. Partner influences and gender-related factors associated with noncondom use among young adult African American women. Am. J. Community Psychol 26, 29–51. [DOI] [PubMed] [Google Scholar]
  67. World Health Organization, 2015. World Health Organization Statistics, 2015. World Health Organization, Geneva: http://www.who.int/gho/publications/world_health_statistics/2015/en/ [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES